These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6431427)

  • 1. The natural history of factor VIII inhibitors in patients with hemophilia A.
    Gill FM
    Prog Clin Biol Res; 1984; 150():19-29. PubMed ID: 6431427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-factor VIII antibodies in children with hemophilia, and the management of hemorrhage].
    Klukowska A; Adamowicz-Salach A; Kamińska D; Zieleniewska B
    Pol Tyg Lek; 1987 Jul; 42(30):911-4. PubMed ID: 3118341
    [No Abstract]   [Full Text] [Related]  

  • 3. Incidence and course of inhibitors among patients with classic hemophilia.
    Kasper CK
    Thromb Diath Haemorrh; 1973 Nov; 30(2):263-71. PubMed ID: 4773365
    [No Abstract]   [Full Text] [Related]  

  • 4. Zero incidence of inhibitors in previously untreated patients who received intermediate purity factor VIII concentrate or factor IX complex.
    Schimpf K; Schwarz P; Kunschak M
    Thromb Haemost; 1995 Mar; 73(3):553-5. PubMed ID: 7667845
    [No Abstract]   [Full Text] [Related]  

  • 5. Factor VIII inhibitors in mild and moderate-severity haemophilia A. UK Haemophilia Centre Directors Organisation.
    Hay CR; Ludlam CA; Colvin BT; Hill FG; Preston FE; Wasseem N; Bagnall R; Peake IR; Berntorp E; Mauser Bunschoten EP; Fijnvandraat K; Kasper CK; White G; Santagostino E
    Thromb Haemost; 1998 Apr; 79(4):762-6. PubMed ID: 9569189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postpartum acquired factor VIII inhibitors.
    Franchini M
    Am J Hematol; 2006 Oct; 81(10):768-73. PubMed ID: 16868941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Occurrence of anti-factor VIII antibodies in children with hemophilia].
    Klukowska A; Adamowicz-Salach A; Kamińska D
    Acta Haematol Pol; 1987; 18(1-2):123-6. PubMed ID: 3124483
    [No Abstract]   [Full Text] [Related]  

  • 8. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group.
    Kessler CM; Ludlam CA
    Semin Hematol; 1993 Apr; 30(2 Suppl 1):22-7. PubMed ID: 8480193
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone.
    Hertzberg MS; Favaloro E; Koutts J
    Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporine treatment of acquired hemophilia due to factor VIII antibodies.
    Petrovic M; Derom E; Baele G
    Haematologica; 2000 Aug; 85(8):895-6. PubMed ID: 10942956
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J
    Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibitors and "bypass" therapy in hemophilia].
    Fukutake K; Fukutake K
    Nihon Rinsho; 1981; 39(12):3688-99. PubMed ID: 6803034
    [No Abstract]   [Full Text] [Related]  

  • 13. Elevation of B cell-activating factor belonging to the tumour necrosis factor [corrected] family (BAFF) in haemophilia A patients with inhibitor.
    Takeda T; Sakurai Y; Tatsumi K; Kato J; Kasuda S; Yoshioka A; Shima M
    Thromb Haemost; 2009 Feb; 101(2):408-10. PubMed ID: 19190830
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid.
    Zhang GS; Zuo WL; Dai CW; Xu YX; Shen JK; Luo YY; Yi Y
    Thromb Haemost; 2006 Nov; 96(5):692-4. PubMed ID: 17080230
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
    Bell BA
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549
    [No Abstract]   [Full Text] [Related]  

  • 17. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acquired autoantibodies against human factor VIII: a new case].
    Cailleux N; Levesque H; Courtois H; Borg JY
    J Mal Vasc; 1996; 21(5):324-8. PubMed ID: 9026552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII gene.
    Tizzano EF; Altisent C; Domènech M; Cornet M; Tusell J; Baiget M
    Thromb Haemost; 1996 Jul; 76(1):125-6. PubMed ID: 8819266
    [No Abstract]   [Full Text] [Related]  

  • 20. Rituximab in the treatment of acquired factor VIII inhibitors.
    Onitilo AA; Skorupa A; Lal A; Ronish E; Mercier RJ; Islam R; Lazarchick J
    Thromb Haemost; 2006 Jul; 96(1):84-7. PubMed ID: 16807656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.